Clinically recognized atrial fibrillation (AF) is associated with higher risk of complications,
including ischemic stroke, cognitive decline, heart failure, myocardial infarction, and death. It …

For new or updated text, view the 2011 Focused Update and the 2011 Focused Update on
Dabigatran. Text supporting unchanged recommendations has not been updated. Atrial …

Atrial fibrillation is a supraventricular tachyarrhythmia with significant consequences in terms
of morbidity and mortality. In light of the limitations of available pharmacologic treatment …

Atrial fibrillation (AF) is a supraventricular tachyarrhythmia characterised by uncoordinated
atria activation with consequent deterioration of atrial mechanical function. It is the most …

Despite being one of the most studied arrhythmias, there is paucity of information regarding
atrial fibrillation (AF) control in the general population and the treatment strategies utilized by …

Atrial fibrillation, a commonly encountered arrhythmia, has in recent years, been the subject
of increased interest and intensive clinical research. There is also increasing awareness that …

Atrial fibrillation (AF) has in recent years been the subject of intense investigation both
regarding a better understanding of its mechanism and improvement of its management …

Abstract Background The World Heart Federation has undertaken an initiative to develop a
series of Roadmaps to promote development of national policies and health systems …

The goals of atrial fibrillation (AF) and atrial flutter (AFL) arrhythmia management are to
alleviate patient symptoms, improve patient quality of life, and minimize the morbidity …

The appropriate use of oral anticoagulants (OACs) for prevention of stroke in atrial fibrillation
(AF) relies on the convenient and accurate stroke risk-prediction scheme: namely, the CHA 2 …